300 related articles for article (PubMed ID: 2491955)
1. Induction of terminal differentiation-resistant epidermal cells in mouse skin and in papillomas by different initiators during two-stage carcinogenesis.
Miller DR; Viaje A; Rotstein J; Aldaz CM; Conti CJ; Slaga TJ
Cancer Res; 1989 Jan; 49(2):410-4. PubMed ID: 2491955
[TBL] [Abstract][Full Text] [Related]
2. Terminal differentiation-resistant epidermal cells in mice undergoing two-stage carcinogenesis.
Miller DR; Viaje A; Aldaz CM; Conti CJ; Slaga TJ
Cancer Res; 1987 Apr; 47(7):1935-40. PubMed ID: 3815381
[TBL] [Abstract][Full Text] [Related]
3. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J
Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681
[TBL] [Abstract][Full Text] [Related]
4. Comparison of two-stage epidermal carcinogenesis initiated by 7,12-dimethylbenz(a)anthracene or N-methyl-N'-nitro-N-nitrosoguanidine in newborn and adult SENCAR and BALB/c mice.
Hennings H; Devor D; Wenk ML; Slaga TJ; Former B; Colburn NH; Bowden GT; Elgjo K; Yuspa SH
Cancer Res; 1981 Mar; 41(3):773-9. PubMed ID: 6780187
[TBL] [Abstract][Full Text] [Related]
5. Squamous cell hyperplastic foci: precursors of cutaneous papillomas induced in SENCAR mice by a two-stage carcinogenesis regimen.
Binder RL; Johnson GR; Gallagher PM; Stockman SL; Sundberg JP; Conti CJ
Cancer Res; 1998 Oct; 58(19):4314-23. PubMed ID: 9766659
[TBL] [Abstract][Full Text] [Related]
6. Development of an in vitro model to study carcinogen-induced neoplastic progression of initiated mouse epidermal cells.
Morgan D; Welty D; Glick A; Greenhalgh D; Hennings H; Yuspa SH
Cancer Res; 1992 Jun; 52(11):3145-56. PubMed ID: 1375535
[TBL] [Abstract][Full Text] [Related]
7. NTP Comparative Initiation/Promotion Skin Paint Studies of B6C3F1 Mice, Swiss (CD-1(R)) Mice, and SENCAR Mice.
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Feb; 441():1-201. PubMed ID: 12595922
[TBL] [Abstract][Full Text] [Related]
8. NTP Initiation/Promotion Study of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in Swiss (CD-1(R)) Mice (Mouse Skin Study).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1995 May; 444():1-136. PubMed ID: 12595919
[TBL] [Abstract][Full Text] [Related]
9. Frequent codon 12 Ki-ras mutations in mouse skin tumors initiated by N-methyl-N'-nitro-N-nitrosoguanidine and promoted by mezerein.
Rehman I; Lowry DT; Adams C; Abdel-Fattah R; Holly A; Yuspa SH; Hennings H
Mol Carcinog; 2000 Apr; 27(4):298-307. PubMed ID: 10747294
[TBL] [Abstract][Full Text] [Related]
10. A course of very small doses of DMBA, each of them allegedly with no promoting potency, acts with clear synergistic effect as a strong promoter of DMBA-initiated mouse skin carcinogenesis. A comparison of the tumorigenic and carcinogenic effects of DMBA (7,12-dimethylbenz-alpha-anthracene) and TPA (12-O-tetradecanoyl-phorbol-13-acetate) used as initiators and promoters in classical two-stage experimental protocols.
Iversen OH
APMIS Suppl; 1994; 41():1-38. PubMed ID: 7946481
[TBL] [Abstract][Full Text] [Related]
11. NTP Toxicology and Carcinogenesis Studies of Diethylphthalate (CAS No. 84-66-2) in F344/N Rats and B6C3F1 Mice (Dermal Studies) with Dermal Initiation/ Promotion Study of Diethylphthalate and Dimethylphthalate (CAS No. 131-11-3) in Male Swiss (CD-1(R)) Mice.
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1995 May; 429():1-286. PubMed ID: 12616302
[TBL] [Abstract][Full Text] [Related]
12. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
Owens DM; Spalding JW; Tennant RW; Smart RC
Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
[TBL] [Abstract][Full Text] [Related]
13. Papilloma development is delayed in osteopontin-null mice: implicating an antiapoptosis role for osteopontin.
Hsieh YH; Juliana MM; Hicks PH; Feng G; Elmets C; Liaw L; Chang PL
Cancer Res; 2006 Jul; 66(14):7119-27. PubMed ID: 16849558
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a new model of tumor progression from carcinogenesis and tumor promotion studies with 7-bromomethylbenz[a]anthracene.
Scribner JD; Scribner NK; McKnight B; Mottet NK
Cancer Res; 1983 May; 43(5):2034-41. PubMed ID: 6403231
[TBL] [Abstract][Full Text] [Related]
15. Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide.
Mancuso M; Pazzaglia S; Tanori M; Rebessi S; Di Majo V; Covelli V; Saran A
Mutat Res; 2004 Apr; 548(1-2):35-45. PubMed ID: 15063134
[TBL] [Abstract][Full Text] [Related]
16. Characterization of skin tumor promotion and progression by chrysarobin in SENCAR mice.
Kruszewski FH; Conti CJ; DiGiovanni J
Cancer Res; 1987 Jul; 47(14):3783-90. PubMed ID: 3109733
[TBL] [Abstract][Full Text] [Related]
17. A model for initiated mouse skin: suppression of papilloma but not carcinoma formation by normal epidermal cells in grafts on athymic nude mice.
Strickland JE; Ueda M; Hennings H; Yuspa SH
Cancer Res; 1992 Mar; 52(6):1439-44. PubMed ID: 1540951
[TBL] [Abstract][Full Text] [Related]
18. Association of resistance to terminal differentiation with initiation of carcinogenesis in adult mouse epidermal cells.
Kawamura H; Strickland JE; Yuspa SH
Cancer Res; 1985 Jun; 45(6):2748-52. PubMed ID: 3921248
[TBL] [Abstract][Full Text] [Related]
19. Dissociation of sensitivities to tumor promotion and progression in outbred and inbred SENCAR mice.
Gimenez-Conti IB; Bianchi AB; Fischer SM; Reiners JJ; Conti CJ; Slaga TJ
Cancer Res; 1992 Jun; 52(12):3432-5. PubMed ID: 1375869
[TBL] [Abstract][Full Text] [Related]
20. Promoter independence as a feature of most skin papillomas in SENCAR mice.
Aldaz CM; Conti CJ; Chen A; Bianchi A; Walker SB; DiGiovanni J
Cancer Res; 1991 Feb; 51(3):1045-50. PubMed ID: 1899044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]